President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis stock fell early Thursday after the drugmaker reported light sales of Cosentyx, one of its biggest moneymakers.

Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, ...

Conversations with the Trump administration on its “most favored nation” policy have been productive, the executive said ...

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

Rather than continuing to retaliate with tariffs of its own, the Canadian government has begun to confess that such a tactic ...

In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

By Noreen Marcus, FloridaBulldog.org - Trump’s tariff assault on drug affordability stings a Vero Beach cancer patient ...

American consumers of Korean cosmetics and skin-care products are bulk buying, as President Trump threatens 25 percent tariffs on imports.

Amazon.com Inc.’s carbon emissions rose for the first time in three years in 2024, driven by data center construction and ...

In April, Trump announced a 25% tariff on U.S. imports from South Korea as part of his broader “Liberation Day” trade package ...